| Year |
Citation |
Score |
| 2019 |
Bommareddy KJ, Kadakuntla A, Kuna M, Shivraj P, Ginnan R, Hohenhaus A, Bennett J, Andersen T. Abstract 2968: Trim25 and KLF5 expression predict AFPep-mediated inhibition of estrogen-dependent growth Cancer Research. 79: 2968-2968. DOI: 10.1158/1538-7445.Am2019-2968 |
0.393 |
|
| 2018 |
Mansouri W, Fordyce SB, Wu M, Jones D, Cohn D, Lin Q, Feustel P, Sharma T, Bennett JA, Andersen TT. Efficacy and tolerability of AFPep, a cyclic peptide with anti-breast cancer properties. Toxicology and Applied Pharmacology. PMID 29518411 DOI: 10.1016/J.Taap.2018.03.004 |
0.484 |
|
| 2017 |
Bennett JA, Mansouri W, Lin Q, Feustel P, Andersen TT. Pharmacodynamic and Pharmacokinetic Properties of AFPep, a Novel Peptide for the Treatment of Breast Cancer International Journal of Peptide Research and Therapeutics. 24: 431-439. DOI: 10.1007/S10989-017-9628-Y |
0.435 |
|
| 2014 |
Jacobson HI, Andersen TT, Bennett JA. Development of an active site peptide analog of α-fetoprotein that prevents breast cancer. Cancer Prevention Research (Philadelphia, Pa.). 7: 565-73. PMID 24706695 DOI: 10.1158/1940-6207.Capr-13-0405 |
0.516 |
|
| 2011 |
Bryan A, Joseph L, Bennett JA, Jacobson HI, Andersen TT. Design and synthesis of biologically active peptides: a 'tail' of amino acids can modulate activity of synthetic cyclic peptides. Peptides. 32: 2504-10. PMID 22015269 DOI: 10.1016/J.Peptides.2011.10.007 |
0.792 |
|
| 2011 |
Dee KC, Andersen TT, Bizios R. Enhanced endothelialization of substrates modified with immobilized bioactive peptides. Tissue Engineering. 1: 135-45. PMID 19877922 DOI: 10.1089/Ten.1995.1.135 |
0.444 |
|
| 2011 |
Mesfin FB, Riccio A, Andersen TT, Bennett J. Abstract 562: Multi-Kinase Inhibitor: AFPep inhibits the growth and invasion of U87 glioblastoma cells through inhibition of FAK, MAPK, and PKC Cancer Research. 71: 562-562. DOI: 10.1158/1538-7445.Am2011-562 |
0.703 |
|
| 2010 |
Jacobson HI, Lemanski N, Agarwal A, Narendran A, Turner KE, Bennett JA, Andersen TT. A proposed unified mechanism for the reduction of human breast cancer risk by the hormones of pregnancy. Cancer Prevention Research (Philadelphia, Pa.). 3: 212-20. PMID 19934340 DOI: 10.1158/1940-6207.Capr-09-0050 |
0.404 |
|
| 2009 |
Tower AM, Trinward A, Lee K, Joseph L, Jacobson HI, Bennett JA, Andersen TT. AFPep, a novel drug for the prevention and treatment of breast cancer, does not disrupt the estrous cycle or fertility in rats. Oncology Reports. 22: 49-56. PMID 19513504 DOI: 10.3892/Or_00000405 |
0.722 |
|
| 2009 |
Joseph LC, Bennett JA, Kirschner KN, Shields GC, Hughes J, Lostritto N, Jacobson HI, Andersen TT. Antiestrogenic and anticancer activities of peptides derived from the active site of alpha-fetoprotein. Journal of Peptide Science : An Official Publication of the European Peptide Society. 15: 319-25. PMID 19189271 DOI: 10.1002/Psc.1119 |
0.796 |
|
| 2008 |
Jacobson HI, Lemanski N, Narendran A, Agarwal A, Bennett JA, Andersen TT. Hormones of pregnancy, alpha-feto protein, and reduction of breast cancer risk. Advances in Experimental Medicine and Biology. 617: 477-84. PMID 18497072 DOI: 10.1007/978-0-387-69080-3_47 |
0.356 |
|
| 2008 |
Sierralta WD, Epuñan MJ, Reyes JM, Valladares LE, Andersen TT, Bennett JA, Jacobson HI, Pino AM. A peptide derived from alpha-fetoprotein inhibits the proliferation induced by estradiol in mammary tumor cells in culture. Oncology Reports. 19: 229-35. PMID 18097600 DOI: 10.3892/Or.19.1.229 |
0.487 |
|
| 2008 |
Jacobson H, Bennett J, Andersen T. Abstract A129: Alpha-fetoprotein-derived peptide (AFPep): A novel drug in translational studies for the treatment and prevention of breast cancer. Cancer Prevention Research. 1. DOI: 10.1158/1940-6207.Prev-08-A129 |
0.44 |
|
| 2008 |
Sierralta WD, Epuñan MJ, Reyes JM, Valladares LE, Andersen TT, Bennett JA, Jacobson HI, Pino AM. A peptide derived from alpha-fetoproteln inhibits the proliferation induced by estradiol in mammary tumor cells in culture Oncology Reports. 19: 229-235. |
0.39 |
|
| 2007 |
Andersen TT, Georgekutty J, Defreest LA, Amaratunga G, Narendran A, Lemanski N, Jacobson HI, Bennett JA. An alpha-fetoprotein-derived peptide reduces the uterine hyperplasia and increases the antitumour effect of tamoxifen. British Journal of Cancer. 97: 327-33. PMID 17637684 DOI: 10.1038/Sj.Bjc.6603882 |
0.54 |
|
| 2007 |
Kirschner KN, Lexa KW, Salisburg AM, Alser KA, Joseph L, Andersen TT, Bennett JA, Jacobson HI, Shields GC. Computational design and experimental discovery of an antiestrogenic peptide derived from alpha-fetoprotein. Journal of the American Chemical Society. 129: 6263-8. PMID 17441722 DOI: 10.1021/Ja070202W |
0.796 |
|
| 2006 |
Bennett JA, DeFreest L, Anaka I, Saadati H, Balulad S, Jacobson HI, Andersen TT. AFPep: an anti-breast cancer peptide that is orally active. Breast Cancer Research and Treatment. 98: 133-41. PMID 16538538 DOI: 10.1007/S10549-005-9140-5 |
0.474 |
|
| 2005 |
Parikh RR, Gildener-Leapman N, Narendran A, Lin HY, Lemanski N, Bennett JA, Jacobson HI, Andersen TT. Prevention of N-methyl-N-nitrosourea-induced breast cancer by alpha-fetoprotein (AFP)-derived peptide, a peptide derived from the active site of AFP. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 8512-20. PMID 16322315 DOI: 10.1158/1078-0432.Ccr-05-1651 |
0.506 |
|
| 2004 |
DeFreest LA, Mesfin FB, Joseph L, McLeod DJ, Stallmer A, Reddy S, Balulad SS, Jacobson HI, Andersen TT, Bennett JA. Synthetic peptide derived from alpha-fetoprotein inhibits growth of human breast cancer: investigation of the pharmacophore and synthesis optimization. The Journal of Peptide Research : Official Journal of the American Peptide Society. 63: 409-19. PMID 15140158 DOI: 10.1111/J.1399-3011.2004.00139.X |
0.792 |
|
| 2003 |
Lin HY, Michtalik HJ, Zhang S, Andersen TT, Van Riper DA, Davies KK, Ermak G, Petti LM, Nachod S, Narayan AV, Bhatt N, Crawford DR. Oxidative and calcium stress regulate DSCR1 (Adapt78/MCIP1) protein. Free Radical Biology & Medicine. 35: 528-39. PMID 12927602 DOI: 10.1016/S0891-5849(03)00358-7 |
0.302 |
|
| 2002 |
Hasenbein ME, Andersen TT, Bizios R. Micropatterned surfaces modified with select peptides promote exclusive interactions with osteoblasts Biomaterials. 23: 3937-3942. PMID 12162326 DOI: 10.1016/S0142-9612(02)00129-1 |
0.478 |
|
| 2002 |
Bennett JA, Mesfin FB, Andersen TT, Gierthy JF, Jacobson HI. A peptide derived from alpha-fetoprotein prevents the growth of estrogen-dependent human breast cancers sensitive and resistant to tamoxifen. Proceedings of the National Academy of Sciences of the United States of America. 99: 2211-5. PMID 11830647 DOI: 10.1073/Pnas.251667098 |
0.794 |
|
| 2001 |
Mesfin FB, Andersen TT, Jacobson HI, Zhu S, Bennett JA. Development of a synthetic cyclized peptide derived from alpha-fetoprotein that prevents the growth of human breast cancer. The Journal of Peptide Research : Official Journal of the American Peptide Society. 58: 246-56. PMID 11576331 DOI: 10.1034/J.1399-3011.2001.00922.X |
0.808 |
|
| 2001 |
Eisele LE, Mesfin FB, Bennett JA, Andersen TT, Jacobson HI, Vakharia DD, MacColl R, Mizejewski GJ. Studies on analogs of a peptide derived from alpha-fetoprotein having antigrowth properties. The Journal of Peptide Research : Official Journal of the American Peptide Society. 57: 539-46. PMID 11437957 DOI: 10.1034/J.1399-3011.2001.00903.X |
0.777 |
|
| 2001 |
Eisele LE, Mesfin FB, Bennett JA, Andersen TT, Jacobson HI, Soldwedel H, MacColl R, Mizejewski GJ. Studies on a growth-inhibitory peptide derived from alpha-fetoprotein and some analogs. The Journal of Peptide Research : Official Journal of the American Peptide Society. 57: 29-38. PMID 11168886 DOI: 10.1034/J.1399-3011.2001.00791.X |
0.783 |
|
| 2000 |
Mesfin FB, Bennett JA, Jacobson HI, Zhu S, Andersen TT. Alpha-fetoprotein-derived antiestrotrophic octapeptide. Biochimica Et Biophysica Acta. 1501: 33-43. PMID 10727847 DOI: 10.1016/S0925-4439(00)00008-9 |
0.804 |
|
| 1999 |
Line BR, Feustel PJ, Festin SM, Andersen TT, Dansereau RN, Lukasiewicz RL, Zhu S, Bennett JA. Scintigraphic detection of breast cancer xenografts with Tc-99m natural and recombinant human alpha-fetoprotein Cancer Biotherapy and Radiopharmaceuticals. 14: 485-494. PMID 10850335 DOI: 10.1089/Cbr.1999.14.485 |
0.371 |
|
| 1999 |
Festin SM, Bennett JA, Fletcher PW, Jacobson HI, Shaye DD, Andersen TT. The recombinant third domain of human alpha-fetoprotein retains the antiestrotrophic activity found in the full-length molecule Biochimica Et Biophysica Acta - General Subjects. 1427: 307-314. PMID 10216247 DOI: 10.1016/S0304-4165(99)00030-6 |
0.427 |
|
| 1999 |
Dee KC, Andersen TT, Bizios R. Osteoblast population migration characteristics on substrates modified with immobilized adhesive peptides Biomaterials. 20: 221-227. PMID 10030598 DOI: 10.1016/S0142-9612(98)00161-6 |
0.421 |
|
| 1998 |
Dee KC, Andersen TT, Bizios R. Design and function of novel osteoblast-adhesive peptides for chemical modification of biomaterials Journal of Biomedical Materials Research. 40: 371-377. PMID 9570067 DOI: 10.1002/(Sici)1097-4636(19980605)40:3<371::Aid-Jbm5>3.0.Co;2-C |
0.514 |
|
| 1997 |
Witting JI, Brezniak DV, Andersen TT, Fenton JW. Thrombin affinity mapping of its receptor tethered ligand. Blood Coagulation & Fibrinolysis : An International Journal in Haemostasis and Thrombosis. 8: 65-9. PMID 9105640 |
0.468 |
|
| 1996 |
Kimura M, Andersen TT, Fenton JW, Bahou WF, Aviv A. Plasmin-platelet interaction involves cleavage of functional thrombin receptor American Journal of Physiology - Cell Physiology. 271. PMID 8760030 |
0.337 |
|
| 1996 |
Olbrich KC, Andersen TT, Blumenstock FA, Bizios R. Surfaces modified with covalently-immobilized adhesive peptides affect fibroblast population motility Biomaterials. 17: 759-764. PMID 8730959 DOI: 10.1016/0142-9612(96)81412-8 |
0.483 |
|
| 1996 |
Dee KC, Rueger DC, Andersen TT, Bizios R. Conditions which promote mineralization at the bone - Implant interface: A model in vitro study Biomaterials. 17: 209-215. PMID 8624397 DOI: 10.1016/0142-9612(96)85765-6 |
0.398 |
|
| 1996 |
Armstrong MT, Fenton JW, Andersen TT, Armstrong PB. Thrombin stimulation of matrix fibronectin. Journal of Cellular Physiology. 166: 112-20. PMID 8557759 DOI: 10.1002/(Sici)1097-4652(199601)166:1<112::Aid-Jcp13>3.0.Co;2-H |
0.384 |
|
| 1994 |
Lum H, Andersen TT, Fenton JW, Malik AB. Thrombin receptor activation peptide induces pulmonary vasoconstriction American Journal of Physiology - Cell Physiology. 266. PMID 8141259 DOI: 10.1152/Ajpcell.1994.266.2.C448 |
0.301 |
|
| 1994 |
Dee KC, Andersen TT, Bizios R. Cell function on substrates containing immobilized bioactive peptides Materials Research Society Symposium Proceedings. 331: 115-119. DOI: 10.1557/Proc-331-115 |
0.483 |
|
| 1994 |
Yüksel KÜ, Andersen TT, Apostol I, Fox JW, Crabb JW, Paxton RJ, Strydom DJ. Amino Acid Analysis of Phospho-Peptides: Abrf-93AAA Techniques in Protein Chemistry. 5: 231-240. DOI: 10.1016/B978-0-12-194710-1.50031-X |
0.448 |
|
| 1993 |
Lum H, Andersen TT, Siflinger-Birnboim A, Tiruppathi C, Goligorsky MS, Fenton JW, Malik AB. Thrombin receptor peptide inhibits thrombin-induced increase in endothelial permeability by receptor desensitization. The Journal of Cell Biology. 120: 1491-9. PMID 8383691 DOI: 10.1083/Jcb.120.6.1491 |
0.349 |
|
| 1993 |
Figge J, Breese K, Vajda S, Zhu QL, Eisele L, Andersen TT, MacColl R, Friedrich T, Smith TF. The binding domain structure of retinoblastoma-binding proteins Protein Science. 2: 155-164. PMID 8382993 DOI: 10.1002/Pro.5560020204 |
0.312 |
|
| 1993 |
Smith TJ, Kottke RJ, Lum H, Andersen TT. Human orbital fibroblasts in culture bind and respond to endothelin American Journal of Physiology - Cell Physiology. 265. PMID 8338122 DOI: 10.1152/Ajpcell.1993.265.1.C138 |
0.362 |
|
| 1993 |
Pinheiro JMB, Andersen TT, Malik AB. Receptor mechanism of thrombin-mediated pulmonary vasodilation in neonates American Journal of Physiology - Lung Cellular and Molecular Physiology. 265. PMID 8238369 DOI: 10.1152/Ajplung.1993.265.4.L355 |
0.397 |
|
| 1993 |
Allen SH, Bennett JA, Mizejewski GJ, Andersen TT, Ferraris S, Jacobson HI. Purification of alpha-fetoprotein from human cord serum with demonstration of its antiestrogenic activity. Biochimica Et Biophysica Acta. 1202: 135-42. PMID 7690596 DOI: 10.1016/0167-4838(93)90074-2 |
0.308 |
|
| 1992 |
Sugama Y, Tiruppathi C, Janakidevi K, Andersen TT, Fenton JW, Malik AB. Thrombin-induced expression of endothelial P-selectin and intercellular adhesion molecule-1: A mechanism for stabilizing neutrophil adhesion Journal of Cell Biology. 119: 935-944. PMID 1385447 DOI: 10.1083/Jcb.119.4.935 |
0.323 |
|
| 1992 |
Tiruppathi C, Lum H, Andersen TT, Fenton JW, Malik AB. Thrombin receptor 14-amino acid peptide binds to endothelial cells and stimulates calcium transients American Journal of Physiology - Lung Cellular and Molecular Physiology. 263. PMID 1332502 DOI: 10.1152/Ajplung.1992.263.5.L595 |
0.365 |
|
| 1991 |
Spinella MJ, Malik AB, Everitt J, Andersen TT. Design and synthesis of a specific endothelin 1 antagonist: Effects on pulmonary vasoconstriction Proceedings of the National Academy of Sciences of the United States of America. 88: 7443-7446. PMID 1871142 DOI: 10.1073/Pnas.88.16.7443 |
0.315 |
|
| 1991 |
Breese K, Friedrich T, Andersen TT, Smith TF, Figge J. Structural characterization of a 14-residue peptide ligand of the retinoblastoma protein: comparison with a nonbinding analog Peptide Research. 4: 220-226. PMID 1823601 |
0.386 |
|
| 1991 |
Vakharia DD, Dias JA, Andersen TT. Determination of subunit contact-associated epitopes of the β-subunit of human follicle-stimulating hormone Endocrinology. 128: 1797-1804. PMID 1706260 DOI: 10.1210/Endo-128-4-1797 |
0.479 |
|
| 1991 |
Andersen TT. Identification of subunit contact sites on the α-subunit of lutropin Biochemistry. 30: 1858-1864. PMID 1704259 DOI: 10.1021/Bi00221A019 |
0.416 |
|
| 1990 |
Vakharia DD, Dias JA, Thakur AN, Andersen TT, O'Shea A. Mapping of an assembled epitope of human follicle-stimulating hormone-β utilizing monoclonal antibodies synthetic peptides, and hormone-receptor inhibition Endocrinology. 127: 658-666. PMID 1695567 DOI: 10.1210/Endo-127-2-658 |
0.492 |
|
| 1990 |
Weiner RS, Andersen TT, Dias JA. Topographic analysis of the α-subunit of human follicle-stimulating hormone using site-specific antipeptide antisera Endocrinology. 127: 573-579. PMID 1695564 DOI: 10.1210/Endo-127-2-573 |
0.361 |
|
| 1990 |
Goodman-Snitkoff G, Eisele LE, Heimer EP, Felix AM, Andersen TT, Fuerst TR, Mannino RJ. Defining minimal requirements for antibody production to peptide antigens. Vaccine. 8: 257-62. PMID 1694612 DOI: 10.1016/0264-410X(90)90055-Q |
0.39 |
|
| 1989 |
Krystek SR, Andersen TT, Weber PB. Cleavage of a model peptide at its glycine residue by alkaline mercuric oxycyanide International Journal of Peptide and Protein Research. 34: 52-55. PMID 2793308 DOI: 10.1111/J.1399-3011.1989.Tb01008.X |
0.486 |
|
| 1989 |
Moon DG, Horgan MJ, Andersen TT, Krystek SR, Fenton JW, Malik AB. Endothelin-like pulmonary vasoconstrictor peptide release by α-thrombin Proceedings of the National Academy of Sciences of the United States of America. 86: 9529-9533. PMID 2687882 DOI: 10.1073/pnas.86.23.9529 |
0.36 |
|
| 1989 |
Sluss PM, Schneyer AL, Andersen TT, Reichert LE. Purification and chemical composition of a low molecular weight follicle-stimulating hormone binding inhibitor from porcine follicular fluid Biology of Reproduction. 41: 863-870. PMID 2516469 DOI: 10.1095/Biolreprod41.5.863 |
0.384 |
|
| 1986 |
Sluss PM, Krystek SR, Andersen TT, Melson BE, Huston JS, Ridge R, Reichert LE. Inhibition of iodine-125-labeled human follitropin binding to testicular receptor by epidermal growth factor and synthetic peptides. Biochemistry. 25: 2644-9. PMID 3013310 DOI: 10.1021/Bi00357A053 |
0.404 |
|
| 1985 |
Krystek SR, Reichert LE, Andersen TT. Analysis of computer-generated hydropathy profiles for human glycoprotein and lactogenic hormones Endocrinology. 117: 1110-1117. PMID 3926466 DOI: 10.1210/Endo-117-3-1110 |
0.336 |
|
| 1985 |
Necessary PC, Andersen TT, Ebner KE. Activity of alkylated prolactin and human growth hormone in receptor and cell assays Molecular and Cellular Endocrinology. 39: 247-254. PMID 2984068 DOI: 10.1016/0303-7207(85)90068-1 |
0.615 |
|
| 1984 |
Andersen TT, Reichert LE. Correlation of B coefficient of viscosity for monovalent salts with effects on binding of human follitropin to receptor Molecular and Cellular Endocrinology. 35: 41-46. PMID 6325278 DOI: 10.1016/0303-7207(84)90028-5 |
0.307 |
|
| 1979 |
Andersen TT, Ebner KE. Reaction of the histidines of prolactin with ethoxyformic anhydride. A binding site modification Journal of Biological Chemistry. 254: 10995-10999. PMID 500618 |
0.609 |
|
| 1979 |
Andersen TT, Zamierowski MM, Ebner KE. Effect of nitration on prolactin activities Archives of Biochemistry and Biophysics. 192: 112-119. PMID 434812 DOI: 10.1016/0003-9861(79)90076-6 |
0.588 |
|
| Show low-probability matches. |